Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: J Rheumatol. 2021 Jan 15;48(8):1299–1306. doi: 10.3899/jrheum.200873

Table 3.

Multivariable linear regression analysis to explore the impact of age, comorbidities, and therapies on GLS in SSc patients.

Variable Beta-coefficient 95% CI p value
Age −0.126 −0.057, 0.011 0.184
Smoking −0.075 −0.898, 0.362 0.401
Dyslipidemia −0.113 −1.618, 0.516 0.309
Diabetes −0.137 −3.057, 0.514 0.161
Hypertension 0.337 0.488, 2.664 0.005
Calcium channel blocker −0.010 −0.874, 0.781 0.912
Beta-blocker 0.041 −1.371, 2.137 0.667
ACE-inhibitor −0.130 −2.020, 0.450 0.211
Angiotensin receptor antagonist 0.048 −1.233, 2.080 0.614
Diuretic −0.008 −1.110, 1.022 0.935
Statin 0.083 −0.797, 1.726 0.468